Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

FUJIFILM IRVINE SCIENTIFIC INC iCELL Cardiomyocytes, 5 x 10^6 viable cells/vial, cryopreserved, >95% cardiomyocytes purity, assay-ready 4 days post-thaw

Supplier:  FUJIFILM IRVINE SCIENTIFIC INC C1058

Encompass

FUJIFILM Irvine Scientific iCell Cardiomyocytes are high-purity, human induced pluripotent stem cell (iPSC)-derived cardiomyocytes tailored for cardiac research applications. These advanced cells serve as a reliable in vitro model for drug discovery, cardiac safety assessments, and disease modeling, exhibiting characteristics that mimic native human cardiomyocytes, such as synchronous beating and electrophysiological responsiveness. They are provided in a cryopreserved format, enabling rapid utilization in experiments.

  • Terminally differentiated from human iPSCs
  • Purity exceeding 95% cardiomyocytes (cTNT+)
  • 5 x 10^6 viable cells per vial
  • Assay-ready in as little as 4 days post-thaw
  • Minimal handling requirements
  • Supported media for plating and maintenance
  • Spontaneous contractile activity and stable gene expression profile
  • Suitable for cardiac safety assessment, drug discovery, and research

Catalog No. NC2389415


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.